Sun Pharmaceutical Industries sees highest patent filings and grants during August in Q3 2023
Sun Pharmaceutical Industries saw the highest growth of 162% in patent filings in August and 159% in grants in September in Q3 2023. Compared to Q2 2023, Q3 2023 saw an increase in patent filings by 61% and grants by 132%. GlobalData's DataBook provides a comprehensive analysis of Sun Pharmaceutical Industries's patent filings and grants. Buy the databook here.Sun Pharmaceutical Industries has been focused on protecting inventions in United States(US) with 15 publications in Q3 2023The United States(US) Patent Office dominates the patent filings and grants with nearly 33% filings and 24% grants. The United States(US), World Intellectual Property Organization(WIPO), European Patent Office(EPO), and Australia(AU) patent Office are among the top ten patent offices where Sun Pharmaceutical Industries is filings its patents. Among the top granted patent authorities, Sun Pharmaceutical Industries has 29% of its grants in Canada(CA), 24% in United States(US), and 10% in European Patent Office(EPO).Amgen could be the strongest competitor for Sun Pharmaceutical IndustriesAmgen and Johnson & Johnson secured the top positions according to recent patent publication data.Patents related to climate change and agricultural biotechnology lead Sun Pharmaceutical Industries's portfolioSun Pharmaceutical Industries has the highest number of patents in climate change followed by, agricultural biotechnology and genetically modified organism (GMO). For climate change, nearly 17% of patents were filed and 0% of patents were granted in Q3 2023.Diabetes related patents lead Sun Pharmaceutical Industries portfolio followed by mobiles, hand-helds, pdas, smartphones, and obesitySun Pharmaceutical Industries has highest number of patents in diabetes followed by mobiles, hand-helds, pdas, smartphones, obesity, hyperlipidemia and type 2 diabetes. For diabetes, nearly 6% of patents were filed and 0% of patents were granted in Q3 2023.For comprehensive analysis of Sun Pharmaceutical Industries's filings and grants, buy the databook here.
Access and buy GlobalData’s databook on the latest filings and grants activity for Sun Pharmaceutical Industries here.
What's Your Reaction?
